Denali Therapeutics (DNLI) Long-Term Deferred Tax (2018)
Denali Therapeutics has reported Long-Term Deferred Tax over the past 1 years, most recently at $23.5 million for Q1 2018.
Denali Therapeutics has reported Long-Term Deferred Tax over the past 1 years, most recently at $23.5 million for Q1 2018.
| Date | Value |
|---|---|
Offer Ends In
Starting from $49 $19 / month